Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 64

1.

The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy.

Knoppova B, Reily C, Maillard N, Rizk DV, Moldoveanu Z, Mestecky J, Raska M, Renfrow MB, Julian BA, Novak J.

Front Immunol. 2016 Apr 12;7:117. doi: 10.3389/fimmu.2016.00117. Review.

2.

Evidence-based clinical practice guidelines for IgA nephropathy 2014.

Yuzawa Y, Yamamoto R, Takahashi K, Katafuchi R, Tomita M, Fujigaki Y, Kitamura H, Goto M, Yasuda T, Sato M, Urushihara M, Kondo S, Kagami S, Yasuda Y, Komatsu H, Takahara M, Harabuchi Y, Kimura K, Matsuo S.

Clin Exp Nephrol. 2016 Aug;20(4):511-35. doi: 10.1007/s10157-015-1223-y. Review. No abstract available.

3.

Recent advances in the understanding and management of IgA nephropathy.

Lai KN, Leung JC, Tang SC.

F1000Res. 2016 Feb 11;5. pii: F1000 Faculty Rev-161. doi: 10.12688/f1000research.7352.1. Review.

4.

Hypertension in Chronic Glomerulonephritis.

Ihm CG.

Electrolyte Blood Press. 2015 Dec;13(2):41-5. doi: 10.5049/EBP.2015.13.2.41. Review.

5.

Human Urine Proteomics: Analytical Techniques and Clinical Applications in Renal Diseases.

Kalantari S, Jafari A, Moradpoor R, Ghasemi E, Khalkhal E.

Int J Proteomics. 2015;2015:782798. doi: 10.1155/2015/782798. Review.

6.

NF-κB in inflammation and renal diseases.

Zhang H, Sun SC.

Cell Biosci. 2015 Nov 16;5:63. doi: 10.1186/s13578-015-0056-4. Review.

7.

Role of complement in IgA nephropathy.

Daha MR, van Kooten C.

J Nephrol. 2016 Feb;29(1):1-4. doi: 10.1007/s40620-015-0245-6. Review.

8.

New developments in the genetics, pathogenesis, and therapy of IgA nephropathy.

Magistroni R, D'Agati VD, Appel GB, Kiryluk K.

Kidney Int. 2015 Nov;88(5):974-89. doi: 10.1038/ki.2015.252. Review.

9.

Role of HIPK2 in kidney fibrosis.

Fan Y, Wang N, Chuang P, He JC.

Kidney Int Suppl (2011). 2014 Nov;4(1):97-101. Review.

10.

The Influence and Role of Microbial Factors in Autoimmune Kidney Diseases: A Systematic Review.

Kronbichler A, Kerschbaum J, Mayer G.

J Immunol Res. 2015;2015:858027. doi: 10.1155/2015/858027. Review.

11.

Primary glomerular diseases in the elderly.

Sumnu A, Gursu M, Ozturk S.

World J Nephrol. 2015 May 6;4(2):263-70. doi: 10.5527/wjn.v4.i2.263. Review.

12.

The Genetics of IgA Nephropathy: An Overview from Western Countries.

Feehally J, Barratt J.

Kidney Dis (Basel). 2015 May;1(1):33-41. doi: 10.1159/000381738. Review.

13.

The Genetics of IgA Nephropathy: An Overview from China.

Zhu L, Zhang H.

Kidney Dis (Basel). 2015 May;1(1):27-32. doi: 10.1159/000381740. Review.

14.

The Treatment of IgA Nephropathy.

Lai KN, Leung JC, Tang SC.

Kidney Dis (Basel). 2015 May;1(1):19-26. doi: 10.1159/000381508. Review.

15.

Diabetic Nephropathy and Treatment of Hypertension.

Arieff AI.

In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
2013 Jan 20.

16.

Leukocyte Cell-Derived Chemotaxin 2-Associated Amyloidosis: A Recently Recognized Disease with Distinct Clinicopathologic Characteristics.

Nasr SH, Dogan A, Larsen CP.

Clin J Am Soc Nephrol. 2015 Nov 6;10(11):2084-93. doi: 10.2215/CJN.12551214. Review.

17.

Current Understanding of the Role of Complement in IgA Nephropathy.

Maillard N, Wyatt RJ, Julian BA, Kiryluk K, Gharavi A, Fremeaux-Bacchi V, Novak J.

J Am Soc Nephrol. 2015 Jul;26(7):1503-12. doi: 10.1681/ASN.2014101000. Review.

18.

Extracapillary proliferation in IgA nephropathy; recent findings and new ideas.

Nasri H, Mubarak M.

J Nephropathol. 2015 Jan;4(1):1-5. doi: 10.12860/jnp.2015.01. Review.

19.

Pathogenesis and treatment of chronic kidney disease: a review of our recent basic and clinical data.

Tomino Y.

Kidney Blood Press Res. 2014;39(5):450-89. doi: 10.1159/000368458. Review.

20.

Efficacy and safety of mycophenolate mofetil treatment in IgA nephropathy: a systematic review.

Chen Y, Li Y, Yang S, Li Y, Liang M.

BMC Nephrol. 2014 Dec 5;15:193. doi: 10.1186/1471-2369-15-193. Review.

Items per page

Supplemental Content

Loading ...
Support Center